Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LLLT vs Botox vs Repositioning Appliance in TMJ Disc Displacement
NCT05194488Completed
- Start
- Jan 2022
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of botulinum toxin type A in temporomandibular joint disc displacement with reduction (3 arms). Primary endpoints: Temporomandibular joint dysfunction at 3 months, Pain level at 3 months and 1 more. Started Jan 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular joint disc displacement with reduction
Beyond the preview
Go deeper on NCT05194488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05194488.